Generation of expression constructs that secrete bioactive αMSH and their use in the treatment of experimental autoimmune encephalomyelitis
- 1 February 2003
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 10 (4), 348-355
- https://doi.org/10.1038/sj.gt.3301902
Abstract
Melanocyte-stimulating hormone (MSH) is a 13 amino acid peptide with potent anti-inflammatory effects. We created two DNA expression constructs (miniPOMC and pACTH1–17) that encode bioactive versions of the MSH peptide, and tested these constructs for therapeutic effects in experimental autoimmune encephalomyelitis (EAE). Each construct contained the sequences for MSH, as well as the sequences that are involved in the secretion and processing of the POMC gene with the assumption that these sequences would promote processing and release of the encoded MSH peptide. The differences between the two constructs lie at the C-terminal end where amino acids necessary for amidation of MSH were included in only the pACTH1–17 construct. These two constructs were tested in vitro in bioassays, and in vivo in a mouse model of EAE. The results show that although bioactive peptides are secreted from cells transfected with either construct, there appears to be a significant therapeutic effect only with the pACTH1–17 construct which contains the extra C-terminal amino acids. The data suggest that it is possible to engineer DNA expression vectors encoding small secreted peptides such as MSH, and that similar type constructs may be useful as therapeutics for the treatment of inflammatory diseases.Keywords
This publication has 30 references indexed in Scilit:
- Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese menInternational Journal of Obesity, 2000
- α‐MSH Can Control the Essential Cofactor 6‐Tetrahydrobiopterin in MelanogenesisAnnals of the New York Academy of Sciences, 1999
- Mechanisms of Antiinflammatory Action of α‐MSH Peptides: In Vivo and in Vitro EvidenceAnnals of the New York Academy of Sciences, 1999
- Proteolytic Processing of Pro-opiomelanocortin Occurs in Acidifying Secretory Granules of AtT-20 CellsJournal of Histochemistry & Cytochemistry, 1997
- The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitroPeptides, 1996
- Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortinBiochimie, 1994
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Inhibits Experimental Arthritis in RatsNeuroimmunomodulation, 1994
- A View of the N-Acetylation of ?-Melanocyte-Stimulating Hormone and ?-Endorphin from a Phylogenetic PerspectiveAnnals of the New York Academy of Sciences, 1993
- Central administration of the peptide α-MSH inhibits inflammation in the skinPeptides, 1991
- Structure-activity studies of highly potent cyclic [Cys4, Cys10]melanotropin analogsJournal of Medicinal Chemistry, 1983